NextEye recorded a record-high consolidated revenue of KRW 182.3 billion in the first nine months of this year, up 175.0% from the same period a year earlier.


NextEye Posts "Record-High" Revenue of KRW 182.3 Billion in First Nine Months View original image

According to NextEye on November 17, the company posted an operating profit of KRW 3 billion and a net profit of KRW 6.5 billion for the first nine months, turning profitable in both measures compared with the same period last year. Its Rodemir business began generating operating profits this year, contributing to the company’s return to profitability on a consolidated basis.


Strong growth at Rodemir, a global beauty platform, drove the results. Rodemir Bio, the U.S. subsidiary that operates the platform, recorded revenue of KRW 174.4 billion and an operating profit of KRW 5.4 billion in the first nine months. Rodemir is a membership-based platform that sells cosmetics and health supplements to consumers in 11 countries and regions, including China, Hong Kong, Taiwan, Vietnam, Malaysia and Canada.


Growth in its membership base and expansion of its product lineup drove revenue growth. The platform’s membership rose more than twofold, from 200,000 at the end of last year to 410,000 at the end of the third quarter, and reached 540,000 as of November. Its product portfolio is also diversifying, with sales contributions from inositol, launched in April this year, and Heracell One, a health supplement made with cultivated wild ginseng roots, in addition to its flagship anti-aging health supplement, Iona Jin AKG.



A NextEye representative said, "Rodemir achieved both revenue growth and a return to profitability as its membership base and product lineup expanded together. We will continue to grow revenue and improve profitability by broadening our product portfolio and expanding into more countries while also improving cost efficiency."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing